Skip to main content
OpenTrials

Clinical trial condition

Respiratory Hypersensitivity

Explore clinical trials studying Respiratory Hypersensitivity. Study availability and eligibility vary by location and protocol.

4,449 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Hypersensitivity trial results

Completed

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

NCT00393991

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Pell City, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Cypress, California, United States
  • Research Site Encinitas, California, United States
View all 57 locations
View Trial Details
Completed

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

NCT00393952

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Center Pell City, Alabama, United States
  • Research Site Glendale, Arizona, United States
  • Research Center Phoenix, Arizona, United States
  • Research Site Phoenix, Arizona, United States
View all 63 locations
View Trial Details
Completed

A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005

NCT00747318

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational Site Scottsdale, Arizona, United States
  • Investigational Site Orange County, California, United States
  • Investigational Site Colorado Springs, Colorado, United States
  • Investigational Site Valrico, Florida, United States
View all 39 locations
View Trial Details
Completed

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma

NCT00394199

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Mission Viejo, California, United States
  • Research Site Orange, California, United States
  • Research Site San Jose, California, United States
View all 41 locations
View Trial Details
Completed

Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients

NCT00830102

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Investigational site Belfast, Ireland
  • Investigational site Derbyshire, United Kingdom
  • Investigational site London, United Kingdom
  • Investigational site Manchester, United Kingdom
View Trial Details

Related conditions